{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:26:43Z","timestamp":1788215203081,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,4]]},"DOI":"10.7759\/cureus.72987","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T16:04:37Z","timestamp":1730736277000},"source":"Crossref","is-referenced-by-count":10,"title":["Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome"],"prefix":"10.7759","author":[{"given":"Chandrani","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srivarshini","family":"Maddukuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.15562\/medicina.v50i1.372","article-title":"Molecular links between angiogenesis and inflammation in polycystic ovary syndrome","volume":"50","author":"Donma O","year":"2019","unstructured":"Donma O, Ozturk EZ, Ekmekci OB, Ocal P, Topcu B. Molecular links between angiogenesis and inflammation in polycystic ovary syndrome. Medicina. 2019, 50:163-7. 10.15562\/medicina.v50i1.372","journal-title":"Medicina"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00213.2021","article-title":"Saturated fat ingestion stimulates proatherogenic inflammation in polycystic ovary syndrome","volume":"321","author":"Gonz\u00e1lez F","year":"2021","unstructured":"Gonz\u00e1lez F, Considine RV, Abdelhadi OA, Xue J, Acton AJ. Saturated fat ingestion stimulates proatherogenic inflammation in polycystic ovary syndrome. Am J Physiol Endocrinol Metab. 2021, 321:E689-701. 10.1152\/ajpendo.00213.2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.16948\/zktipb.679178","article-title":"Increased fetuin-B levels are associated with carotid intima media thickness and hormonal-metabolic disturbances in women with polycystic ovary syndrome","volume":"51","author":"Bay\u0131nd\u0131r A","year":"2020","unstructured":"Bay\u0131nd\u0131r A, Unal G, \u0130mamo\u011flu C, Alan Y. Increased fetuin-B levels are associated with carotid intima media thickness and hormonal-metabolic disturbances in women with polycystic ovary syndrome. Zeynep Kamil T\u0131p B\u00fclteni. 2020, 51:106-12. 10.16948\/zktipb.679178","journal-title":"Zeynep Kamil T\u0131p B\u00fclteni"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.22038\/jmrh.2020.44188.1527","article-title":"The effect of aerobic exercise training on biochemical and inflammatory markers among young females suffering from polycystic ovary syndrome","volume":"8","author":"Jafari S","year":"2020","unstructured":"Jafari S, Taghian F. The effect of aerobic exercise training on biochemical and inflammatory markers among young females suffering from polycystic ovary syndrome. J Midwifery Reprod Health. 2020, 8:2194-202. 10.22038\/jmrh.2020.44188.1527","journal-title":"J Midwifery Reprod Health"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-020-00576-1","article-title":"Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression","volume":"18","author":"Amiri M","year":"2020","unstructured":"Amiri M, Ramezani Tehrani F, Behboudi-Gandevani S, Bidhendi-Yarandi R, Carmina E. Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Reprod Biol Endocrinol. 2020, 18:23. 10.1186\/s12958-020-00576-1","journal-title":"Reprod Biol Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4274\/tjod.galenos.2022.29498","article-title":"The role of inflammation, oxidation and cystatin-C in the pathophysiology of polycystic ovary syndrome","volume":"19","author":"\u00d6zdemir Ba\u015fer \u00d6","year":"2022","unstructured":"\u00d6zdemir Ba\u015fer \u00d6, G\u00f6\u00e7men AY, Aydo\u011fan K\u0131rm\u0131z\u0131 D. The role of inflammation, oxidation and cystatin-C in the pathophysiology of polycystic ovary syndrome. Turk J Obstet Gynecol. 2022, 19:229-35. 10.4274\/tjod.galenos.2022.29498","journal-title":"Turk J Obstet Gynecol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01594-5","article-title":"Effect of aging on clinical features and metabolic complications of women with polycystic ovary syndrome","volume":"44","author":"Falcetta P","year":"2021","unstructured":"Falcetta P, Benelli E, Molinaro A, et al.. Effect of aging on clinical features and metabolic complications of women with polycystic ovary syndrome. J Endocrinol Invest. 2021, 44:2725-33. 10.1007\/s40618-021-01594-5","journal-title":"J Endocrinol Invest"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2023.2259793","article-title":"Reproductive milestones across the lifespan and cardiovascular disease risk in women","volume":"27","author":"Stuenkel CA","year":"2024","unstructured":"Stuenkel CA. Reproductive milestones across the lifespan and cardiovascular disease risk in women. Climacteric. 2024, 27:5-15. 10.1080\/13697137.2023.2259793","journal-title":"Climacteric"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249554","article-title":"Pharmacological approaches to controlling cardiometabolic risk in women with PCOS","volume":"21","author":"Cignarella A","year":"2020","unstructured":"Cignarella A, Mioni R, Sabbadin C, et al.. Pharmacological approaches to controlling cardiometabolic risk in women with PCOS. Int J Mol Sci. 2020, 21:10.3390\/ijms21249554","journal-title":"Int J Mol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis","volume":"26","author":"Wekker V","year":"2020","unstructured":"Wekker V, van Dammen L, Koning A, et al.. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update. 2020, 26:942-60. 10.1093\/humupd\/dmaa029","journal-title":"Hum Reprod Update"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5603\/EP.a2019.0006","article-title":"Recomendations on non-pharmacological interventions in women with PCOS to reduce body weight and improve metabolic disorders [Article in Polish]","volume":"70","author":"Dutkowska A","year":"2019","unstructured":"Dutkowska A, Konieczna A, Breska-Kruszewska J, Sendrakowska M, Kowalska I, Racho\u0144 D. Recomendations on non-pharmacological interventions in women with PCOS to reduce body weight and improve metabolic disorders [Article in Polish]. Endokrynol Pol. 2019, 70:198-212. 10.5603\/EP.a2019.0006","journal-title":"Endokrynol Pol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10081989","article-title":"Therapeutic potential of glucagon-like peptide-1 agonists in polycystic ovary syndrome: from current clinical evidence to future perspectives","volume":"10","author":"Jensterle M","year":"2022","unstructured":"Jensterle M, Herman R, Jane\u017e A. Therapeutic potential of glucagon-like peptide-1 agonists in polycystic ovary syndrome: from current clinical evidence to future perspectives. Biomedicines. 2022, 10:10.3390\/biomedicines10081989","journal-title":"Biomedicines"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112171","article-title":"Polycystic ovary syndrome and cardiovascular risk. Could trimethylamine N-oxide (TMAO) be a major player? A potential upgrade forward in the DOGMA theory","volume":"143","author":"Annunziata G","year":"2021","unstructured":"Annunziata G, Ciampaglia R, Cap\u00f2 X, Guerra F, Sureda A, Tenore GC, Novellino E. Polycystic ovary syndrome and cardiovascular risk. Could trimethylamine N-oxide (TMAO) be a major player? A potential upgrade forward in the DOGMA theory. Biomed Pharmacother. 2021, 143:112171. 10.1016\/j.biopha.2021.112171","journal-title":"Biomed Pharmacother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2022.03.009","article-title":"Polycystic ovary syndrome: a \"risk-enhancing\" factor for cardiovascular disease","volume":"117","author":"Guan C","year":"2022","unstructured":"Guan C, Zahid S, Minhas AS, Ouyang P, Vaught A, Baker VL, Michos ED. Polycystic ovary syndrome: a \"risk-enhancing\" factor for cardiovascular disease. Fertil Steril. 2022, 117:924-35. 10.1016\/j.fertnstert.2022.03.009","journal-title":"Fertil Steril"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1117761","article-title":"High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome","volume":"14","author":"Butler AE","year":"2023","unstructured":"Butler AE, Moin AS, Reiner \u017d, Sathyapalan T, Jamialahmadi T, Sahebkar A, Atkin SL. High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome. Front Endocrinol (Lausanne). 2023, 14:1117761. 10.3389\/fendo.2023.1117761","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/1179558119871467","article-title":"The source of polycystic ovarian syndrome","volume":"13","author":"Raperport C","year":"2019","unstructured":"Raperport C, Homburg R. The source of polycystic ovarian syndrome. Clin Med Insights Reprod Health. 2019, 13:1179558119871467. 10.1177\/1179558119871467","journal-title":"Clin Med Insights Reprod Health"},{"key":"ref18","article-title":"Metabolic syndrome in women with and without polycystic syndrome, a case control study in Iran","volume":"6","author":"Montazerifar F","year":"2020","unstructured":"Montazerifar F, Ghasemi M, Arabpour N, Karajibani M, Keikhah N. Metabolic syndrome in women with and without polycystic syndrome, a case control study in Iran. Caspian J Reprod Med. 2020, 6:9-15.","journal-title":"Caspian J Reprod Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2022.02.028","article-title":"Subclinical cardiovascular disease and polycystic ovary syndrome","volume":"117","author":"Gomez JM","year":"2022","unstructured":"Gomez JM, VanHise K, Stachenfeld N, Chan JL, Merz NB, Shufelt C. Subclinical cardiovascular disease and polycystic ovary syndrome. Fertil Steril. 2022, 117:912-23. 10.1016\/j.fertnstert.2022.02.028","journal-title":"Fertil Steril"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_30_19","article-title":"Comparison of the different PCOS phenotypes based on clinical metabolic, and hormonal profile, and their response to clomiphene","volume":"23","author":"Sachdeva G","year":"2019","unstructured":"Sachdeva G, Gainder S, Suri V, Sachdeva N, Chopra S. Comparison of the different PCOS phenotypes based on clinical metabolic, and hormonal profile, and their response to clomiphene. Indian J Endocrinol Metab. 2019, 23:326-31. 10.4103\/ijem.IJEM_30_19","journal-title":"Indian J Endocrinol Metab"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.17925\/EE.2021.17.1.37","article-title":"Assessment of early markers of cardiovascular risk in polycystic ovary syndrome","volume":"17","author":"Alexandraki KI","year":"2021","unstructured":"Alexandraki KI, Kandaraki EA, Poulia KA, Piperi C, Papadimitriou E, Papaioannou TG. Assessment of early markers of cardiovascular risk in polycystic ovary syndrome. touchREV Endocrinol. 2021, 17:37-53. 10.17925\/EE.2021.17.1.37","journal-title":"touchREV Endocrinol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.822079","article-title":"Cardiovascular risk according to body mass index in women of reproductive age with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"9","author":"Zhuang C","year":"2022","unstructured":"Zhuang C, Luo X, Wang W, Sun R, Qi M, Yu J. Cardiovascular risk according to body mass index in women of reproductive age with polycystic ovary syndrome: a systematic review and meta-analysis. Front Cardiovasc Med. 2022, 9:822079. 10.3389\/fcvm.2022.822079","journal-title":"Front Cardiovasc Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0232299","article-title":"Carotid intima-media thickness in polycystic ovary syndrome and its association with hormone and lipid profiles","volume":"15","author":"Jabbour R","year":"2020","unstructured":"Jabbour R, Ott J, Eppel W, Frigo P. Carotid intima-media thickness in polycystic ovary syndrome and its association with hormone and lipid profiles. PLoS One. 2020, 15:e0232299. 10.1371\/journal.pone.0232299","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0002052022","article-title":"Polycystic ovary syndrome: Insights from preclinical research","volume":"3","author":"Reckelhoff JF","year":"2022","unstructured":"Reckelhoff JF, Shawky NM, Romero DG, Yanes Cardozo LL. Polycystic ovary syndrome: Insights from preclinical research. Kidney360. 2022, 3:1449-57. 10.34067\/KID.0002052022","journal-title":"Kidney360"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/children9010004","article-title":"Cardiovascular risk factors and subclinical atherosclerosis in Greek adolescents with polycystic ovary syndrome: its relationship with body mass index","volume":"9","author":"Garoufi A","year":"2021","unstructured":"Garoufi A, Pagoni A, Papadaki M, Marmarinos A, Karapostolakis G, Michala L, Soldatou A. Cardiovascular risk factors and subclinical atherosclerosis in Greek adolescents with polycystic ovary syndrome: its relationship with body mass index. Children (Basel). 2021, 9:10.3390\/children9010004","journal-title":"Children (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073789","article-title":"Chronic low grade inflammation in pathogenesis of PCOS","volume":"22","author":"Rudnicka E","year":"2021","unstructured":"Rudnicka E, Suchta K, Grymowicz M, et al.. Chronic low grade inflammation in pathogenesis of PCOS. Int J Mol Sci. 2021, 22:10.3390\/ijms22073789","journal-title":"Int J Mol Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_1937_17","article-title":"Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India","volume":"150","author":"Ganie MA","year":"2019","unstructured":"Ganie MA, Vasudevan V, Wani IA, Baba MS, Arif T, Rashid A. Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. Indian J Med Res. 2019, 150:333-44. 10.4103\/ijmr.IJMR_1937_17","journal-title":"Indian J Med Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520934633","article-title":"Increased risk markers in women with polycystic ovary syndrome and gestational diabetes mellitus during mid-pregnancy","volume":"48","author":"Zhang L","year":"2020","unstructured":"Zhang L, Zhang L, Wang Z, Zhu L, Wang H, Chen H, Zhang H. Increased risk markers in women with polycystic ovary syndrome and gestational diabetes mellitus during mid-pregnancy. J Int Med Res. 2020, 48:300060520934633. 10.1177\/0300060520934633","journal-title":"J Int Med Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6657658","article-title":"Serum fetuin-B levels are elevated in women with metabolic syndrome and associated with increased oxidative stress","volume":"2021","author":"Xue S","year":"2021","unstructured":"Xue S, Han H, Rui S, et al.. Serum fetuin-B levels are elevated in women with metabolic syndrome and associated with increased oxidative stress. Oxid Med Cell Longev. 2021, 2021:6657658. 10.1155\/2021\/6657658","journal-title":"Oxid Med Cell Longev"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/2483435","article-title":"Elevated circulating fetuin-B levels are associated with insulin resistance and reduced by GLP\u20101RA in newly diagnosed PCOS women","volume":"2020","author":"Mokou M","year":"2020","unstructured":"Mokou M, Yang S, Zhan B, et al.. Elevated circulating fetuin-B levels are associated with insulin resistance and reduced by GLP\u20101RA in newly diagnosed PCOS women. Mediators Inflamm. 2020, 2020:2483435. 10.1155\/2020\/2483435","journal-title":"Mediators Inflamm"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11120869","article-title":"Metabolic syndrome and PCOS: pathogenesis and the role of metabolites","volume":"11","author":"Chen W","year":"2021","unstructured":"Chen W, Pang Y. Metabolic syndrome and PCOS: pathogenesis and the role of metabolites. Metabolites. 2021, 11:10.3390\/metabo11120869","journal-title":"Metabolites"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-019-0486-9","article-title":"PCOS without hyperandrogenism is associated with higher plasma trimethylamine N-oxide levels","volume":"20","author":"Huang J","year":"2020","unstructured":"Huang J, Liu L, Chen C, Gao Y. PCOS without hyperandrogenism is associated with higher plasma trimethylamine N-oxide levels. BMC Endocr Disord. 2020, 20:3. 10.1186\/s12902-019-0486-9","journal-title":"BMC Endocr Disord"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.20200860","article-title":"The importance of inflammation markers in polycystic ovary syndrome","volume":"67","author":"\u00d6zay AC","year":"2021","unstructured":"\u00d6zay AC, \u00d6zay \u00d6E. The importance of inflammation markers in polycystic ovary syndrome. Rev Assoc Med Bras (1992). 2021, 67:411-7. 10.1590\/1806-9282.20200860","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.21608\/BMFJ.2023.176005.1715","article-title":"Evaluation of the cardiovascular risk in women with PCOS","volume":"41","author":"Al-Kassas A","year":"2024","unstructured":"Al-Kassas A, Mohammed R, Elian M. Evaluation of the cardiovascular risk in women with PCOS. Benha Med. J. 2024, 41:10-22. 10.21608\/BMFJ.2023.176005.1715","journal-title":"Benha Med. J"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212507","article-title":"Anti-M\u00fcllerian hormone in pathogenesis, diagnostic and treatment of PCOS","volume":"22","author":"Rudnicka E","year":"2021","unstructured":"Rudnicka E, Kunicki M, Calik-Ksepka A, Suchta K, Duszewska A, Smolarczyk K, Smolarczyk R. Anti-M\u00fcllerian hormone in pathogenesis, diagnostic and treatment of PCOS. Int J Mol Sci. 2021, 22:10.3390\/ijms222212507","journal-title":"Int J Mol Sci"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00641","article-title":"Role of anti-M\u00fcllerian hormone in the pathogenesis of polycystic ovary syndrome","volume":"11","author":"Dewailly D","year":"2020","unstructured":"Dewailly D, Barbotin AL, Dumont A, Catteau-Jonard S, Robin G. Role of anti-M\u00fcllerian hormone in the pathogenesis of polycystic ovary syndrome. Front Endocrinol (Lausanne). 2020, 11:641. 10.3389\/fendo.2020.00641","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-018-1760-8","article-title":"Effects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial","volume":"58","author":"Trummer C","year":"2019","unstructured":"Trummer C, Schwetz V, Kollmann M, et al.. Effects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial. Eur J Nutr. 2019, 58:2019-28. 10.1007\/s00394-018-1760-8","journal-title":"Eur J Nutr"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/nu11112831","article-title":"Vitamin D levels in women with polycystic ovary syndrome: a population-based study","volume":"11","author":"Lumme J","year":"2019","unstructured":"Lumme J, Sebert S, Pesonen P, et al.. Vitamin D levels in women with polycystic ovary syndrome: a population-based study. Nutrients. 2019, 11:10.3390\/nu11112831","journal-title":"Nutrients"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2021.958","article-title":"An update on contraception in polycystic ovary syndrome","volume":"36","author":"Oguz SH","year":"2021","unstructured":"Oguz SH, Yildiz BO. An update on contraception in polycystic ovary syndrome. Endocrinol Metab (Seoul). 2021, 36:296-311. 10.3803\/EnM.2021.958","journal-title":"Endocrinol Metab (Seoul)"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14913","article-title":"Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: a systematic review","volume":"99","author":"Forslund M","year":"2023","unstructured":"Forslund M, Melin J, Alesi S, et al.. Combined oral contraceptive pill compared with no medical treatment in the management of polycystic ovary syndrome: a systematic review. Clin Endocrinol (Oxf). 2023, 99:79-91. 10.1111\/cen.14913","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60020244","article-title":"The current and emerging role of statins in the treatment of PCOS: the evidence to date","volume":"60","author":"Kolnikaj TS","year":"2024","unstructured":"Kolnikaj TS, Herman R, Jane\u017e A, Jensterle M. The current and emerging role of statins in the treatment of PCOS: the evidence to date. Medicina (Kaunas). 2024, 60:10.3390\/medicina60020244","journal-title":"Medicina (Kaunas)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/276661-beyond-hormones-a-systematic-review-of-the-risk-of-cardiovascular-diseases-in-polycystic-ovary-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T16:04:38Z","timestamp":1730736278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/276661-beyond-hormones-a-systematic-review-of-the-risk-of-cardiovascular-diseases-in-polycystic-ovary-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,4]]},"references-count":41,"URL":"https:\/\/doi.org\/10.7759\/cureus.72987","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,4]]}}}